Private company

DUSA Pharmaceuticals

American pharmaceutical company

DUSA Pharmaceuticals, Inc. was an American pharmaceutical company specializing in dermatological products and treatments.³ From Wikipedia, CC BY-SA 4.0

Last updated Oct 18, 2026.

Overview

IndustryPharmaceutical Preparations¹
HeadquartersNJ¹
Listed onNasdaq¹
Incorporated inNJ⁴
Business address25 Upton Drive, Wilmington, Ma 01887⁴
Filer categoryLarge Accelerated⁴

See how the biggest companies compare on our leaderboards

DUSA Pharmaceuticals, Inc. was an American pharmaceutical company specializing in dermatological products and treatments. It was founded in 1991 by Canadian dermatologist and pharmaceutical executive D. Geoffrey Shulman, who served as the company's chairman, president and chief executive officer.³

The story

In the first quarter of 2006, DUSA acquired Sirius Laboratories in a transaction valued at approximately $30 million. Sirius was a privately held specialty pharmaceutical company founded by dermatologist Joel E. Bernstein in 2000. It developed treatments for conditions including acne vulgaris and rosacea.

In June 2007, Robert F. Doman was elected chief executive officer. Shulman remained chairman of the board and assumed the position of chief strategic officer. In April 2008, DUSA announced that Shulman's role was expected to change because of a serious illness. His employment agreement was terminated in December 2008 and replaced by a part-time consulting arrangement, with company filings citing his health.

In 2012, Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharmaceutical, acquired DUSA.

From Wikipedia’s article on DUSA Pharmaceuticals, shared under CC BY-SA 4.0.⁵

Leadership

Who has led DUSA Pharmaceuticals, and when. Pick a name to see everywhere that person has worked.

Chief executive

2010201520202025

Chief executive officerRobert F. Doman May 12, 2008 to Dec 20, 2012⁶
Chief executive officerD. Geoffrey Shulman Mar 20, 2006 to Mar 21, 2007⁷
ChairD. Geoffrey Shulman Mar 20, 2006 to May 13, 2008⁷
PresidentRobert F. Doman Mar 20, 2006 to Dec 20, 2012⁸
Chief financial officerRichard Christopher Mar 29, 2006 to Dec 20, 2012⁹
Chief operating officerRobert F. Doman Mar 20, 2006 to Nov 14, 2007⁸

Board members and other officers (18)

Vice President, OperationsMark Carota Mar 29, 2006 to Dec 20, 2012¹⁰
VP Marketing & SalesPaul A. Sowyrda Mar 29, 2006 to Mar 29, 2006¹¹
VP, Regulatory Affairs & IPScott L. Lundahl Mar 29, 2006 to Dec 20, 2012¹²
VP, Sc. Aff & CMOStuart L. Marcus Mar 29, 2006 to Dec 20, 2012¹³
Exec. VP Sales and MarketingWilliam F. Odell Apr 5, 2006 to Dec 20, 2012¹⁴
Vice President, ControllerMichael Todisco Sep 19, 2006 to Dec 20, 2012¹⁵
Board memberAlfred Altomari Aug 2, 2010 to Dec 20, 2012¹⁶
Board memberDavid M. Wurzer Aug 2, 2010 to Dec 20, 2012¹⁷
Board memberPaul J. Hondros Aug 4, 2010 to Dec 20, 2012¹⁸
Board memberAlexander W. Casdin Feb 3, 2009 to Dec 20, 2012¹⁹
Board memberMarvin E. Lesser Jun 11, 2009 to Jul 1, 2010²⁰
Board memberRobert F. Doman Mar 21, 2007 to Dec 20, 2012²¹
Board memberNeal Stuart Penneys Mar 14, 2006 to Aug 8, 2006²²
Board memberDavid M. Bartash Jul 5, 2006 to Dec 20, 2012²³
Board memberJay M. Haft Jul 5, 2006 to Dec 20, 2012²⁴
Board memberJohn H. Abeles Jul 5, 2006 to Jul 1, 2010²⁵
Board memberMagnus Moliteus Jul 5, 2006 to Dec 20, 2012²⁶
Board memberRichard C. Lufkin Jul 5, 2006 to Jul 1, 2010²⁷

Timeline

May 12, 2008New chief executive Robert F. Doman becomes CEO⁶
Mar 20, 2006New chief executive D. Geoffrey Shulman becomes CEO⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataDUSA Pharmaceuticals on Wikidata
2
SEC EDGARDUSA Pharmaceuticals filings on SEC EDGAR
3
WikipediaDUSA Pharmaceuticals on Wikipedia
4
SEC EDGARDUSA Pharmaceuticals filings on SEC EDGAR
5
WikipediaDUSA Pharmaceuticals on Wikipedia (revision used)
6
SEC EDGARRobert F. Doman, Chief executive officer
7
SEC EDGARD. Geoffrey Shulman, Chief executive officer
8
SEC EDGARRobert F. Doman, President
9
SEC EDGARRichard Christopher, Chief financial officer
10
SEC EDGARMark Carota, Vice President, Operations
11
SEC EDGARPaul A. Sowyrda, VP Marketing & Sales
12
SEC EDGARScott L. Lundahl, VP, Regulatory Affairs & IP
13
SEC EDGARStuart L. Marcus, VP, Sc. Aff & CMO
14
SEC EDGARWilliam F. Odell, Exec. VP Sales and Marketing
15
SEC EDGARMichael Todisco, Vice President, Controller
16
SEC EDGARAlfred Altomari, Board member
17
SEC EDGARDavid M. Wurzer, Board member
18
SEC EDGARPaul J. Hondros, Board member
19
SEC EDGARAlexander W. Casdin, Board member
20
SEC EDGARMarvin E. Lesser, Board member
21
SEC EDGARRobert F. Doman, Board member
22
SEC EDGARNeal Stuart Penneys, Board member
23
SEC EDGARDavid M. Bartash, Board member
24
SEC EDGARJay M. Haft, Board member
25
SEC EDGARJohn H. Abeles, Board member
26
SEC EDGARMagnus Moliteus, Board member
27
SEC EDGARRichard C. Lufkin, Board member

Overview

The story

Leadership

Chief executive

Chair

President

Chief financial officer

Chief operating officer

Timeline

Links

Sources